Gianluca Campo

Showing 1-7 of 7 articles

Author Hirofumi Hioki

Coronary interventions

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study

Hioki H, Brugaletta S, Ishida K, Campo G, Biscaglia S, Ortega-Paz L, Cortese B, Varricchio A, Latib A, Sabaté M, Tespili M, Ielasi A

May 20, 2019 | 10.4244/EIJ-D-18-00504

Author Giosafat Spitaleri

STEMI

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iniguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabaté M

March 20, 2018 | 10.4244/EIJ-D-17-00608

Author Bernard Chevalier

Stents and scaffolds

Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

Chevalier B, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Reith S, de Sousa Almeida M, Campo G, Iniguez A, Onuma Y, Serruys P

January 19, 2018 | 10.4244/EIJ-D-17-00873

Author Luis Ortega-Paz

Coronary interventions

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabaté M

August 4, 2017 | 10.4244/EIJ-D-16-00512

Author Pascal Vranckx

Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction

Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, Moreno R, Piva T, Favero L, Prati F, Nazzaro M, Fern J, Ferrari R, Valgimigli M

May 15, 2012 | 10.4244/EIJV8I1A12

Author E Varani

Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation

Varani E, Guastaroba P, Di Tanna G, Saia F, Balducelli M, Campo G, Vignali L, Rossi R, Manari A, Piovaccari G, De Palma R, Marzocchi A

April 12, 2010

Author F Saia

Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry

Saia F, Piovaccari G, Manari A, Guastaroba P, Vignali L, Varani E, Santarelli A, Benassi A, Liso A, Campo G, Tondi S, Tarantino F, De Palma R, Marzocchi A

May 19, 2009

1

Latest news

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

January 17, 2020

This week's JAA's: Transcatheter therapy after ASD closure, LAmbre for occluding LAAA & more

January 28, 2020

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

Last week's JAA's: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke